Intraoperative Pharmacotherapeutic Blood Management Strategies in Total Knee Arthroplasty

2013 ◽  
Vol 26 (06) ◽  
pp. 379-386 ◽  
Author(s):  
Samik Banerjee ◽  
Kimona Issa ◽  
Robert Pivec ◽  
Mark McElroy ◽  
Harpal Khanuja ◽  
...  
2018 ◽  
Vol 10 (1) ◽  
pp. 8-16 ◽  
Author(s):  
Qiang Lu ◽  
Hao Peng ◽  
Guan-jin Zhou ◽  
Dong Yin

2014 ◽  
Vol 22 (6) ◽  
pp. 361-371 ◽  
Author(s):  
Brett Russell Levine ◽  
Bryan Haughom ◽  
Benjamin Strong ◽  
Michael Hellman ◽  
Rachel M. Frank

2013 ◽  
Vol 26 (06) ◽  
pp. 401-404 ◽  
Author(s):  
Kimona Issa ◽  
Samik Banerjee ◽  
Aiman Rifai ◽  
Bhaveen Kapadia ◽  
Steven Harwin ◽  
...  

2013 ◽  
Vol 26 (06) ◽  
pp. 387-394 ◽  
Author(s):  
Samik Banerjee ◽  
Kimona Issa ◽  
Bhaveen Kapadia ◽  
Harpal Khanuja ◽  
Steven Harwin ◽  
...  

2013 ◽  
Vol 26 (06) ◽  
pp. 371-372 ◽  
Author(s):  
Steven Harwin ◽  
Bhaveen Kapadia ◽  
Kimona Issa ◽  
Michael Mont

2016 ◽  
Vol 28 (3) ◽  
pp. 179-187 ◽  
Author(s):  
David Liu ◽  
FRACS ◽  
Michael Dan ◽  
Sara Martinez Martos ◽  
Elaine Beller

2013 ◽  
Vol 26 (06) ◽  
pp. 373-378 ◽  
Author(s):  
Bhaveen Kapadia ◽  
Samik Banerjee ◽  
Kimona Issa ◽  
Mark McElroy ◽  
Steven Harwin ◽  
...  

Author(s):  
Jared A. Warren ◽  
John P. McLaughlin ◽  
Robert M. Molloy ◽  
Carlos A. Higuera ◽  
Jonathan L. Schaffer ◽  
...  

AbstractBoth advances in perioperative blood management, anesthesia, and surgical technique have improved transfusion rates following primary total knee arthroplasty (TKA), and have driven substantial change in preoperative blood ordering protocols. Therefore, blood management in TKA has seen substantial changes with the implementation of preoperative screening, patient optimization, and intra- and postoperative advances. Thus, the purpose of this study was to examine changes in blood management in primary TKA, a nationwide sample, to assess gaps and opportunities. The American College of Surgeons National Surgical Quality Improvement Program database was used to identify TKA (n = 337,160) cases from 2011 to 2018. The following variables examined, such as preoperative hematocrit (HCT), anemia (HCT <35.5% for females and <38.5% for males), platelet count, thrombocytopenia (platelet count < 150,000/µL), international normalized ration (INR), INR > 2.0, bleeding disorders, preoperative, and postoperative transfusions. Analysis of variances were used to examine changes in continuous variables, and Chi-squared tests were used for categorical variables. There was a substantial decrease in postoperative transfusions from high of 18.3% in 2011 to a low of 1.0% in 2018, (p < 0.001), as well as in preoperative anemia from a high of 13.3% in 2011 to a low of 9.5% in 2016 to 2017 (p < 0.001). There were statistically significant, but clinically irrelevant changes in the other variables examined. There was a HCT high of 41.2 in 2016 and a low of 40.4 in 2011 to 2012 (p < 0.001). There was platelet count high of 247,400 in 2018 and a low of 242,700 in 201 (p < 0.001). There was a high incidence of thrombocytopenia of 5.2% in 2017 and a low of low of 4.4% in 2018 (p < 0.001). There was a high INR of 1.037 in 2011 and a low of 1.021 in 2013 (p < 0.001). There was a high incidence of INR >2.0 of 1.0% in 2012 to 2015 and a low of 0.8% in 2016 to 2018 (p = 0.027). There was a high incidence of bleeding disorders of 2.9% in 2013 and a low of 1.8% in 2017 to 2018 (p < 0.001). There was a high incidence of preoperative transfusions of 0.1% in 2011 to 2014 and a low of <0.1% in 2015 to 2018 (p = 0.021). From 2011 to 2018, there has been substantial decreases in patients receiving postoperative transfusions after primary TKA. Similarly, although a decrease in patients with anemia was seen, there remains 1 out 10 patients with preoperative anemia, highlighting the opportunity to further improve and address this potentially modifiable risk factor before surgery. These findings may reflect changes during TKA patient selection, optimization, or management, and emphasizes the need to further advance multimodal approaches for perioperative blood management of TKA patients. This is a Level III study.


2004 ◽  
Vol 124 (5) ◽  
pp. 317-319 ◽  
Author(s):  
Yukihide Minoda ◽  
Akira Sakawa ◽  
Shinichi Fukuoka ◽  
Koichi Tada ◽  
Kunio Takaoka

2019 ◽  
Vol 33 (01) ◽  
pp. 034-041 ◽  
Author(s):  
Theodore S. Wolfson ◽  
David Novikov ◽  
Kevin K. Chen ◽  
Kelvin Y. Kim ◽  
Afshin A. Anoushiravani ◽  
...  

AbstractDespite the evolution of blood management protocols, total knee arthroplasty (TKA) occasionally requires allogeneic blood transfusion. This poses a particular challenge for Jehovah's Witnesses (JW) who believe that the Bible strictly prohibits the use of blood products. The aim of this study was to compare JW and a matched-control cohort of non-JW candidates undergoing TKA to assess the safety using modern blood management protocols. Fifty-five JW patients (63 knees) who underwent TKA at our institution between 2005 and 2017 were matched to 63 non-JW patients (63 knees). Patient demographics, intraoperative details, and postoperative complications including in-hospital complications, revisions, and 90-day readmissions were collected and compared between the groups. Additionally, subgroup analysis was performed comparing JW patients who were administered tranexamic acid (TXA) between the two groups. Baseline demographics did not vary significantly between the study cohorts. The mean follow-up was 3.1 years in both the JW and non-JW cohorts. Postoperative complications, including in-hospital complications (7.9 vs. 4.8%; p = 0.47), revision TKA (1.6 vs. 1.6%; p = 1.00), and 90-day readmission (1.6 vs. 4.8%; p = 0.31) were not significantly different between the JW and non-JW groups. Subgroup analysis demonstrated JW patients who received TXA had a significantly lower decline in postoperative hemoglobin (Hgb) (8.6 vs. 14.0%; p < 0.01). At a follow-up of up to 12 years, JW patients who underwent TKA have outcomes equivalent to non-JW patients without the need for transfusion. Our findings support that surgeons are more likely to optimize JW patients preoperatively with iron and folate supplementation. Despite these variations in preoperative optimization efforts, no significant difference with regard to Hgb or hematocrit levels was demonstrated. Level of evidence is III, retrospective observational study.


Sign in / Sign up

Export Citation Format

Share Document